CO4810376A1 - Derivados de eritromicina triciclicos - Google Patents
Derivados de eritromicina triciclicosInfo
- Publication number
- CO4810376A1 CO4810376A1 CO98063690A CO98063690A CO4810376A1 CO 4810376 A1 CO4810376 A1 CO 4810376A1 CO 98063690 A CO98063690 A CO 98063690A CO 98063690 A CO98063690 A CO 98063690A CO 4810376 A1 CO4810376 A1 CO 4810376A1
- Authority
- CO
- Colombia
- Prior art keywords
- tricyclic
- formula
- compounds
- erythromycine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A COMPUESTOS FE LA FORMULA I Y A SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS,EN LA QUE R1,R2,R3,R4 Y R5 SON COMO SE HAN DEFINIDO EN ESTE DOCUMENTO.LA INVENCION TAMBIEN SE REFIERE A COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPUESTOS DE FORMULA I,A APROCEDIMIENTOS PARA USAR DICHOS COMPUESTOS DE FORMULA I EN EL TRATAMIENTO DE INFECCIONES Y A PROCEDIMIENTOS PARA PREPARAR DICHOS COMPUESTOS DE FORMULA I.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6316197P | 1997-10-29 | 1997-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4810376A1 true CO4810376A1 (es) | 1999-06-30 |
Family
ID=22047342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO98063690A CO4810376A1 (es) | 1997-10-29 | 1998-10-29 | Derivados de eritromicina triciclicos |
Country Status (11)
Country | Link |
---|---|
US (1) | US6291656B1 (es) |
AP (1) | AP9801377A0 (es) |
AR (1) | AR018016A1 (es) |
AU (1) | AU9277398A (es) |
CO (1) | CO4810376A1 (es) |
GT (1) | GT199800162A (es) |
MA (1) | MA24685A1 (es) |
PA (1) | PA8461401A1 (es) |
PE (1) | PE122399A1 (es) |
TN (1) | TNSN98196A1 (es) |
WO (1) | WO1999021865A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6710033B1 (en) | 1996-08-14 | 2004-03-23 | Vanderbilt University | Methods and treatment of multiple sclerosis |
US6890526B2 (en) | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
AP9801420A0 (en) * | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
ATE243219T1 (de) * | 1998-04-24 | 2003-07-15 | Pfizer Prod Inc | 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin |
AU3439899A (en) * | 1998-06-03 | 1999-12-20 | Pfizer Products Inc. | Tricyclic 3-keto derivatives of 6-o-methylerythromycin |
WO2000071557A1 (en) * | 1999-05-24 | 2000-11-30 | Pfizer Products Inc. | 13-methyl-erythromycin derivatives |
US6498146B1 (en) * | 1999-10-28 | 2002-12-24 | Pfizer Inc | Erythromycin derivatives |
EP1146051A3 (en) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Erythromycin A derivatives |
US20020115621A1 (en) * | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
US20070003508A1 (en) * | 2005-07-01 | 2007-01-04 | Wooley Richard E | Methods and compositions for promoting wound healing |
US20040151765A1 (en) * | 2001-09-18 | 2004-08-05 | Ritchie Branson W. | Methods and compositions for wound management |
US20040208842A1 (en) * | 2001-09-18 | 2004-10-21 | Ritchie Branson W. | Antimicrobial cleansing compositions and methods of use |
EP1836211B1 (en) * | 2004-12-21 | 2010-03-03 | Pfizer Products Inc. | Macrolides |
CN104971324A (zh) * | 2015-06-16 | 2015-10-14 | 四川金堂海纳生物医药技术研究所 | 一种治疗产后发热的汤剂药物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993021199A1 (en) | 1992-04-22 | 1993-10-28 | Taisho Pharmaceutical Co., Ltd. | 5-o-desosaminylerythronolide a derivative |
JP2000500133A (ja) | 1995-11-08 | 2000-01-11 | アボツト・ラボラトリーズ | 三環式エリスロマイシン誘導体 |
-
1998
- 1998-10-06 PA PA19988461401A patent/PA8461401A1/es unknown
- 1998-10-08 WO PCT/IB1998/001559 patent/WO1999021865A1/en active Application Filing
- 1998-10-08 US US09/341,888 patent/US6291656B1/en not_active Expired - Fee Related
- 1998-10-08 AU AU92773/98A patent/AU9277398A/en not_active Abandoned
- 1998-10-22 PE PE1998000992A patent/PE122399A1/es not_active Application Discontinuation
- 1998-10-23 GT GT199800162A patent/GT199800162A/es unknown
- 1998-10-27 AR ARP980105378A patent/AR018016A1/es not_active Application Discontinuation
- 1998-10-28 MA MA25318A patent/MA24685A1/fr unknown
- 1998-10-28 TN TNTNSN98196A patent/TNSN98196A1/fr unknown
- 1998-10-29 CO CO98063690A patent/CO4810376A1/es unknown
- 1998-11-02 AP APAP/P/1998/001377A patent/AP9801377A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999021865A1 (en) | 1999-05-06 |
MA24685A1 (fr) | 1999-07-01 |
AP9801377A0 (en) | 2000-04-29 |
PE122399A1 (es) | 1999-12-02 |
US6291656B1 (en) | 2001-09-18 |
TNSN98196A1 (fr) | 2005-03-15 |
AU9277398A (en) | 1999-05-17 |
GT199800162A (es) | 2000-04-15 |
AR018016A1 (es) | 2001-10-31 |
PA8461401A1 (es) | 2000-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4810375A1 (es) | Derivados de 9-amino-3-ceto eritromicina | |
PA8495101A1 (es) | Derivados de 13-metileritromicina | |
AR028948A1 (es) | Compuestos novedosos | |
AR023574A1 (es) | Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios | |
CO4930259A1 (es) | Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen | |
PA8442001A1 (es) | Derivados de pirimidina biciclica condensada | |
GT200100137A (es) | Pro-drogas de derivados de 4-fenil-piridina. | |
ES2196377T3 (es) | Derivados de naftiridina. | |
SV2002000504A (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal ref.pc10760/20205/bb | |
PA8547701A1 (es) | Nucleosidos 4 substituidos. | |
CO4810376A1 (es) | Derivados de eritromicina triciclicos | |
CR6726A (es) | Compuestos azapoliciclicos condensados con arilo | |
PA8551001A1 (es) | Nuevos compuestos | |
ECSP034444A (es) | Derivados de 4-amino-6-fenil-pirrolo(2,3-d)pirimidina | |
CO5271715A1 (es) | 7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa | |
AR023727A1 (es) | Compuestos empleados en el tratamiento de padecimientos inflamatorios | |
ECSP099371A (es) | INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA | |
ES2139959T3 (es) | Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2. | |
PA8556901A1 (es) | Nuevos derivados de piperazina | |
PA8451801A1 (es) | Derivados de la 9-oxima eritromicina | |
PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
ES2243579T3 (es) | Derivados de pirazolopirideno. | |
PA8576001A1 (es) | "difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion , medicamentos que comprenden estos compuestos y su uso". | |
UY26920A1 (es) | 7 - oxo piridopirimidinas | |
SE9901077D0 (sv) | Novel use |